TSTomoki Sumida

Tomoki Sumida

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tomoki Sumida has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Targeting Id1 reduces proliferation and invasion in aggressive human salivary gland cancer cells

    by Tomoki Sumida, Ryuichi Murase, Akiko Onishi-Ishikawa, Sean D McAllister, Hiroyuki Hamakawa, Pierre-Yves Desprez

    Salivary gland cancer (SGC) is one of the common malignancies of the head and neck area. It develops in the minor and major salivary glands and sometimes metastasizes to other organs, particularly to the lungs. Inhibitors of differentiation (Id) proteins are negative regulators of basic helix-loop-helix transcription factors that control malignant cell behavior and tumor aggressiveness in many tissues. In this study, our goal was to determine the potential role of Id proteins, particularly Id1, during human SGC cell progression.


    • 1 October 2012
      • Vol. 5  (8) , 830-3

    Epulis-like gingival angiosarcoma of the mandible: a case report.

    by Tomoki Sumida, Ryuichi Murase, Yohei Fujita, Akiko Ishikawa, Hiroyuki Hamakawa

    A 55-year-old woman consulted our hospital for an epulis-like small mass in the anterior region of the mandible. A biopsy of the tumor was performed. Histological analysis showed that the tumor consisted of spindle-shaped and polygonal cells with hyperchromatic nuclei, and intracytoplasmic vacuoles and mitotic figures were scattered. Immunohistochemical staining revealed that the tumor cells were positive for factor VIII-related antigen, CD31, αSMA, and vimentin, but negative for pancytokeratins, S100 protein, neuron-specific enolase, and CD56. The Ki-67 labeling index was more than 50%. Based on these findings, a final pathological diagnosis of angiosarcoma was made. The tumor did not invade into the surrounding tissue. The operation was performed with about a 20-mm surgical margin that was negative for tumor invasion. After a 4-year follow-up, no metastatic lesions were found, and the primary site was covered with a partial denture.


  • Massive subcutaneous emphysema developing before surgery for mandibular fracture: a case report

    by Tomoki Sumida, Ayumi Kobayashi, Ryota Oka, Toshihiro Yorozuya, Takumi Nagaro, Hiroyuki Hamakawa

    Abstract –  Preoperative massive subcutaneous emphysema before intubation is extremely rare. However, this complication may be potentially lethal, depend on the condition of air spreading. Subcutaneous emphysema which occurs intra‐ or postoperative period is sometimes iatrogenic because the air is introduced into the tissue space through the hole injured by the operation. But the emphysema in this case occurred preoperatively by the pressure of the bag valve mask, because the patient had an intra‐oral wound, which reaches the submental space. In this report, we describe an extremely rare case of preoperative massive emphysema of the patient with the mandibular fracture.


    • 1 November 2003
      • Vol. 63  (21) , 7098-105

    Role of Id-2 in the maintenance of a differentiated and noninvasive phenotype in breast cancer cells.

    by Yoko Itahana, Jarnail Singh, Tomoki Sumida, Jean-Philippe Coppe, Simona Parrinello, James L Bennington, Pierre-Yves Desprez

    Id proteins are inhibitors of basic helix-loop-helix transcription factors and generally stimulate cell proliferation and inhibit differentiation. We have shown that ectopic expression of Id-1 in murine mammary epithelial cells resulted in loss of differentiation and gain of invasive and proliferative abilities. Moreover, Id-1 was highly expressed in aggressive breast cancer cells in culture and in biopsies from infiltrating carcinomas. In contrast to Id-1, we found that, in vitro and in vivo, Id-2 mRNA and protein were up-regulated as mammary epithelial cells lost proliferative capacity and initiated differentiation. We further determined that this up-regulation of Id-2 was a necessary step toward a fully differentiated phenotype in breast cells. Here we show that one of the components of the extracellular matrix network, laminin, is responsible for the increase in Id-2 expression during differentiation. We also show that Id-2 expression is inversely correlated with the rate of proliferation in murine mammary epithelial cells and that Id-2 is expressed at a higher level in differentiated human breast cancer cells in comparison with very aggressive and metastatic cells. When reintroduced in aggressive breast cancer cells, Id-2 is able to reduce their proliferative and invasive phenotypes and decrease their level of matrix metalloproteinase 9 secretion as well as increase syndecan-1 expression. Moreover, little Id-2 protein expression is detectable in human biopsies from aggressive and invasive carcinomas in comparison with in situ carcinomas. In conclusion, Id-2 expression not only follows a pattern opposite to that of Id-1 during mammary gland development and breast cancer progression but also appears to act as an important protein for the maintenance of a differentiated and noninvasive phenotype in normal and transformed breast cells.


  • A case of submandibular malignant rhabdoid tumor transformed from papillary thyroid carcinoma

    by Tomoki Sumida, Hiroyuki Hamakawa, Misako Imaoka, Noriko Okamoto, Manabu Takarada, Hiroaki Tanioka, Norifumi Ueda, Masato Nose


  • Telomerase and oral cancer

    by T Sumida, H Hamakawa


  • Leiomyosarcoma of the maxillary sinus with cervical lymph node metastasis

    by Tomoki Sumida, Hiroyuki Hamakawa, Koji Otsuka, Hiroaki Tanioka